Amalgamated Bank’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43K | Sell |
3,678
-2,735
| -43% | -$32K | ﹤0.01% | 1862 |
|
2025
Q1 | $56K | Buy |
6,413
+561
| +10% | +$4.9K | ﹤0.01% | 1783 |
|
2024
Q4 | $84K | Sell |
5,852
-317
| -5% | -$4.55K | ﹤0.01% | 1739 |
|
2024
Q3 | $139K | Hold |
6,169
| – | – | ﹤0.01% | 1647 |
|
2024
Q2 | $120K | Buy |
6,169
+152
| +3% | +$2.96K | ﹤0.01% | 1683 |
|
2024
Q1 | $226K | Sell |
6,017
-12,632
| -68% | -$474K | ﹤0.01% | 1568 |
|
2023
Q4 | $1.04M | Sell |
18,649
-3,887
| -17% | -$218K | 0.01% | 1150 |
|
2023
Q3 | $930K | Buy |
22,536
+2,538
| +13% | +$105K | 0.01% | 1147 |
|
2023
Q2 | $1.12M | Buy |
19,998
+1,128
| +6% | +$63K | 0.01% | 1093 |
|
2023
Q1 | $1.05M | Sell |
18,870
-1,920
| -9% | -$107K | 0.01% | 1101 |
|
2022
Q4 | $758K | Buy |
20,790
+342
| +2% | +$12.5K | 0.01% | 1261 |
|
2022
Q3 | $582K | Buy |
20,448
+535
| +3% | +$15.2K | 0.01% | 1364 |
|
2022
Q2 | $901K | Buy |
19,913
+362
| +2% | +$16.4K | 0.01% | 1189 |
|
2022
Q1 | $1.49M | Buy |
19,551
+1,602
| +9% | +$122K | 0.01% | 1044 |
|
2021
Q4 | $2.67M | Buy |
17,949
+2,244
| +14% | +$334K | 0.02% | 805 |
|
2021
Q3 | $2.29M | Sell |
15,705
-923
| -6% | -$134K | 0.02% | 863 |
|
2021
Q2 | $3.26M | Buy |
16,628
+5,998
| +56% | +$1.17M | 0.03% | 750 |
|
2021
Q1 | $1.92M | Sell |
10,630
-985
| -8% | -$178K | 0.07% | 251 |
|
2020
Q4 | $1.65M | Sell |
11,615
-2
| -0% | -$283 | 0.06% | 309 |
|
2020
Q3 | $1.45M | Buy |
11,617
+331
| +3% | +$41.3K | 0.06% | 308 |
|
2020
Q2 | $1.01M | Buy |
+11,286
| New | +$1.01M | 0.05% | 417 |
|